The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 2, 1995, Pages 603-607

  Ditkoff, Edward C ^a   Fruzzetti, Franca ^b   Chang, Lilly ^c   Stancyzk, Frank Z ^c   Lobo, Rogerio A ^c  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYANDROSTENEDIONE; ANDROSTENEDIONE; CORTICOTROPIN RELEASING FACTOR; ESTROGEN; LEUPRORELIN; PRASTERONE; STEROID 17,20 LYASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HYPERANDROGENISM; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

17-HYDROXYPROGESTERONE; ADRENAL GLANDS; ADULT; ANDROGENS; ANDROSTENEDIONE; ANIMAL; CORTICOTROPIN; CORTICOTROPIN-RELEASING HORMONE; ESTRADIOL; FEMALE; HUMAN; HYDROXYPROGESTERONES; LEUPROLIDE; POLYCYSTIC OVARY SYNDROME; SHEEP;

EID: 0028854941     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.2.7852527     Document Type: Article

References (23)

1. Hoffman DI, Klove K, Lobo RA. 1984 The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril. 42:76-81.
2. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. 1992 Does ethnicity influence the prevalence of adrenal hyperandrogenims and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol. 167:1807-1812.
3. Mongioi A, Macchi M, Vicari E, et al. 1988 Pituitary and adrenal response to ovine corticotropin-releasing hormone in women with polycystic ovarian syndrome. J Endocrinol Invest. 11:637-640.
4. Lobo RA. 1984 The role of the adrenal in polycystic ovary syndrome. Semin Reprod Endocrinol. 2:251-262.
5. Carmina E, Levin JH, Malizia G, Lobo RA. 1990 Ovine corticotropin-releasing factor and dexamethasone responses in hyperandrogenic women. Fertil Steril. 54:245-250.
6. Carmina E, Lobo RA. 1990 Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in other hyperandrogenic patients. Gynecol Endocrinol. 4:225-232.
7. Hague WM, Honour JW, Adams J, Vecsei P, Jacobs HS. 1989 Steroid responses to ACTH in women with polycystic ovaries. Clin Endocrinol (Oxf). 30:355-365.
8. Gibson M, Lackritz R, Schiff I, Tulchinsky D. 1980 Abnormal adrenal responses to adrenocorticotropic hormone in hyperandrogenic women. Fertil Steril. 33:43-48.
9. Azziz R, Gay FL, Potter SR, Bradley Jr E, Boots LR. 1991 The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women. J Clin Endocrinol Metab. 72:1025-1030.
10. Futterweit W, Green G, Tarlin N, Dunaif A. 1992 Chronic high dosage androgen administration to ovulatory women does not alter adrenocortical steroidogenesis. Fertil Steril. 58:124-128.
11. Vermesh M, Silva PD, Rosen GF, Vijod AG, Lobo RA. 1988 Effect of androgen on adrenal steroidogenesis in normal women. J Clin Endocrinol Metab. 66:128-130.
12. Fruzzetti F, Melis GB, Mais V, et al. 1991 High testosterone levels of ovarian origin affect adrenal steroidogenesis? J Clin Endocrinol Metab. 72:426-431.
13. Sharma DC, Forchielli E, Dorfman RI. 1973 Inhibition of enzymatic steroid 11β-hydroxylation by androgens. J Biol Chem. 238: 572-580.
14. Leventhal ML, Scommegna A. 1963 Multiglandular aspects of the Stein-Leventhal syndrome. Am J Obstet Gynecol. 87:445-454.
15. DeVane GW, Czekala NM, Judd HL, Yen SSC. 1975 Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol. 121:496-500.
16. Lobo RA, Granger L, Goebelsmann U, Mishell Jr DR. 1981 Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metab. 52:156-158.
17. Rosenfield RL, Barnes RB, Cara JF, Lucky AW. 1990 Dysregulation of cytochrome P450cl7α as the cause of polycystic ovarian syndrome. Fertil Steril. 53:785-791.
18. Lobo RA, Goebelsmann U, Brenner PF, Mishell Jr DR. 1982 The effect of estrogen on adrenal androgens in oophorectomized women. Am J Obstet Gynecol. 142:471-478.
19. Schiebinger R, Albertson B, Cassorla F, et al. Changes in adrenal enzyme activity associated with human adrenarche. Proc of the 62nd Annual Meet of The Endocrine Soc. 1980. (Abstract 533).
20. Barnes RB, Mileikowsky GN, Cha KY, Spencer CA, Lobo RA. 1986 Effects of dopamine and metoclopramide in polycystic ovary syndrome. J Clin Endocrinol Metab. 63:506-509.
21. Lobo RA, Paul WL, Goebelsmann U. 1981 Dehydroepiandros-terone sulfate as an indicator of adrenal androgen function. Obstet Gynecol. 57:69-73.
22. Stanczyk FZ, Chang L, Carmina E, Putz Z, Lobo RA. 1991 Is 11β-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate? Am J Obstet Gynecol. 165:1837-1842.
23. Lobo RA, Goebelsmann U. 1981 Evidence for reduced 3β-ol-hy-droxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome. J Clin Endocrinol Metab. 53:394-400.